Swiss National Bank Sells 99,300 Shares of Aflac Incorporated (NYSE:AFL)

Swiss National Bank trimmed its position in Aflac Incorporated (NYSE:AFL - Free Report) by 6.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,502,900 shares of the financial services provider's stock after selling 99,300 shares during the period. Swiss National Bank owned approximately 0.27% of Aflac worth $155,460,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Whipplewood Advisors LLC acquired a new stake in Aflac in the fourth quarter worth $26,000. Darwin Wealth Management LLC acquired a new stake in shares of Aflac during the third quarter worth about $34,000. BankPlus Trust Department bought a new position in shares of Aflac during the 4th quarter valued at about $34,000. Raelipskie Partnership acquired a new position in shares of Aflac in the 3rd quarter valued at approximately $38,000. Finally, Covestor Ltd increased its stake in Aflac by 41.8% during the 3rd quarter. Covestor Ltd now owns 363 shares of the financial services provider's stock worth $41,000 after purchasing an additional 107 shares in the last quarter. Institutional investors own 67.44% of the company's stock.

Insider Transactions at Aflac

In other Aflac news, EVP Audrey B. Tillman sold 24,744 shares of the business's stock in a transaction dated Friday, December 27th. The shares were sold at an average price of $103.40, for a total value of $2,558,529.60. Following the completion of the sale, the executive vice president now owns 222,618 shares of the company's stock, valued at $23,018,701.20. The trade was a 10.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Charles D. Lake II sold 29,802 shares of the stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the transaction, the director now owns 49,962 shares in the company, valued at approximately $5,360,422.98. The trade was a 37.36 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 55,546 shares of company stock worth $5,863,616. Company insiders own 0.90% of the company's stock.

Remove Ads

Aflac Stock Performance

NYSE:AFL traded up $1.22 on Monday, hitting $108.47. The company's stock had a trading volume of 1,344,188 shares, compared to its average volume of 1,994,443. Aflac Incorporated has a one year low of $79.31 and a one year high of $115.50. The firm has a market capitalization of $59.29 billion, a P/E ratio of 11.30, a price-to-earnings-growth ratio of 3.24 and a beta of 0.93. The stock has a fifty day moving average of $105.37 and a two-hundred day moving average of $107.68. The company has a current ratio of 0.10, a quick ratio of 0.08 and a debt-to-equity ratio of 0.29.

Aflac (NYSE:AFL - Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. Research analysts predict that Aflac Incorporated will post 6.88 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on AFL. Evercore ISI reduced their price target on shares of Aflac from $104.00 to $102.00 and set an "underperform" rating for the company in a report on Wednesday, December 4th. Piper Sandler lowered their target price on Aflac from $122.00 to $118.00 and set an "overweight" rating for the company in a report on Friday, February 7th. StockNews.com upgraded Aflac from a "sell" rating to a "hold" rating in a report on Friday, February 14th. Morgan Stanley lifted their target price on Aflac from $98.00 to $105.00 and gave the company an "equal weight" rating in a research report on Friday, February 28th. Finally, Keefe, Bruyette & Woods reduced their price target on Aflac from $107.00 to $104.00 and set a "market perform" rating for the company in a research report on Wednesday, February 12th. Two research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $103.36.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.